RECURRENT OR METASTATIC CERVICAL CANCER

Clinical trials for RECURRENT OR METASTATIC CERVICAL CANCER explained in plain language.

Never miss a new study

Get alerted when new RECURRENT OR METASTATIC CERVICAL CANCER trials appear

Sign up with your email to follow new studies for RECURRENT OR METASTATIC CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for women with advanced cervical cancer after standard treatments fail

Disease control Recruiting now

This study is testing an experimental drug called SHR-A1811 for women with advanced cervical cancer that has returned or spread and no longer responds to standard treatments. The trial will enroll 60 participants to see if the drug can shrink tumors and control the cancer. Resear…

Matched conditions: RECURRENT OR METASTATIC CERVICAL CANCER

Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC

RECURRENT OR METASTATIC CERVICAL CANCER

Get alerted when new RECURRENT OR METASTATIC CERVICAL CANCER trials appear

New hope for women with advanced cervical cancer after standard treatments fail